Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
about
Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerA Role for Notch Signalling in Breast Cancer and Endocrine ResistanceSynthetic androgens as designer supplementsPredicting Adherence to Aromatase Inhibitor Therapy among Breast Cancer Survivors: An Application of the Protection Motivation Theory.Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agentsModifying effects of IL-6 polymorphisms on body size-associated breast cancer risk.Aromatase inhibitors to augment height: continued caution and study required.The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistanceClinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2- Metastatic Breast CancerAromatase inhibitors as add-on treatment for men with epilepsy.Genotoxic effects of some l-[(benzofuran-2-yl)-phenylmethyl]-imidazoles on MCF-7 cell line.Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies.Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations.Role of phytoestrogens in cancer therapy.A suite of activity-based probes for human cytochrome P450 enzymes.Adjuvant treatment of breast cancer in postmenopausal women: role of exemestane.The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.Drug safety evaluation of exemestane.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice.Exploring the chemical space of aromatase inhibitors.Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitors.Three-dimensional model of cytochrome P450 human aromatase.Sex-dependent effects of letrozole on anxiety in middle-aged rats.Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole.
P2860
Q24670339-12315073-52D5-4C0E-B60F-BACEDE18C2C0Q26765912-2AB2B373-1615-4E26-A672-4218C80CB98AQ28263449-F1F2C155-D720-4138-A2C1-3434D9D83AC5Q33562869-2FFE7263-7B9C-488A-9D31-5B6D20322004Q33992426-77D61DAD-8F91-4E37-871D-D1E110D4E66DQ34042275-9049733E-A202-4EC3-88C5-263137D9F973Q34078811-D1F6EA84-2A4B-4B71-AECC-BB7AF6158653Q34423627-66DDFB82-B64C-4ADB-AD8D-A1A04684FBBDQ35939435-C89C618F-393B-4709-88C8-D36C8BFDC9E4Q36028961-72257000-7099-4C53-8722-7FAEF57FDBB7Q36106781-A6B55900-0289-4B23-BB3A-FAF811F01CEBQ36410869-D1E42D68-85F5-4E68-944B-16EA877A29BCQ36675384-9D2A5D1A-FC7C-486F-917E-3B3FA18F2AE2Q36740503-C96513AC-2EC0-4D72-9FB5-0ADB47DD7402Q36967279-154F88F5-B44D-4E1C-A26A-8A75204B04E0Q37238391-7CE23399-6EAA-43C8-9F81-9077F2B8E494Q37331285-E55D139F-A3EE-4719-9C64-7A99ADC59307Q37355561-6A4F8FFD-1A2C-43E8-B219-2C1EB7DB3484Q37395245-C1E5859B-C3BF-49C8-A184-39097AFA54AEQ37856307-E6588A69-7B53-4964-B61C-CFBDD8E1049DQ38707618-ED6F1B5A-4304-4C66-B3D2-70D6D116B499Q39765023-099DA039-70FB-4380-A0BE-ED2A269C7A4BQ45191655-0BDA3CAC-80FB-425F-B5DA-A99D3E8CDD86Q46884372-7054C034-014A-4F33-8206-74AA810E0BE0Q46891612-50EAF975-B8D1-485D-9C4E-661B13ED39B5Q47888820-B72B4F77-DCF9-4F37-90EB-7711206F2695Q53307237-480D9EF3-459B-4556-98C7-4BDFDE29F382
P2860
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@ast
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@en
type
label
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@ast
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@en
prefLabel
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@ast
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@en
P1433
P1476
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer.
@en
P2093
William R Miller
P356
10.1016/S0093-7754(03)00302-6
P433
4 Suppl 14
P577
2003-08-01T00:00:00Z